Apatinib in combination with S-1 as first-line treatment in patients with advanced gastric cancer: A phase II clinical trial.

Zhang, CT; Liu, ZM; Zhou, N; Zhang, JL; Zhu, JJ; Lv, HY; Li, TJ; Hou, HL; Liu, D; Cong, J; Jiang, M; Liu, KW; Cui, ZM; Zhou, YB; Zhang, XC

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (4):